Commonwealth Equity Services
GNCA

Commonwealth Equity Services’s Genocea Biosciences, Inc. GNCA Stock Holding History

Commonwealth Equity Services’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,069
Closed -$50K – 3864
2022
Q1 		$50K Buy
40,069
+8,088
+25% +$8.81K ﹤0.01% 3581
2021
Q4 		$37K Buy
31,981
+10,576
+49% +$15.8K ﹤0.01% 3562
2021
Q3 		$41K Buy
21,405
+700
+3% +$1.38K ﹤0.01% 3510
2021
Q2 		$48K Hold
20,705
– – ﹤0.01% 3465
2021
Q1 		$56K Buy
20,705
+2,784
+16% +$8.24K ﹤0.01% 3325
2020
Q4 		$43K Buy
17,921
+3,900
+28% +$8.88K ﹤0.01% 3141
2020
Q3 		$32K Buy
14,021
+41
+0.3% +$108 ﹤0.01% 2985
2020
Q2 		$32K Hold
13,980
– – ﹤0.01% 2882
2020
Q1 		$24K Buy
+13,980
New +$28.2K ﹤0.01% 2747
2019
Q2 		– Sell
-2,997
Closed -$14K – 2850
2019
Q1 		$14K Sell
2,997
-125
-4% -$618 ﹤0.01% 2718
2018
Q4 		$7K Hold
3,122
– – ﹤0.01% 2661
2018
Q3 		$19K Buy
3,122
+988
+46% +$5.21K ﹤0.01% 2748
2018
Q2 		$15K Buy
2,134
+31
+1% +$232 ﹤0.01% 2739
2018
Q1 		$17K Buy
+2,103
New +$17.5K ﹤0.01% 2670

Other funds holding GNCA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Commonwealth Equity Services's GNCA Position: Q2 2022 in Review

Commonwealth Equity Services sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 40,069 shares — an estimated $50K sold.

Commonwealth Equity Services first reported a position in GNCA in Q1 2018 and held it in 14 quarters. The position peaked at $56K in Q1 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

  • Commonwealth Equity Services reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 40,069 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $50K.
  • Commonwealth Equity Services first reported a position in Genocea Biosciences, Inc. in Q1 2018 and held it in 14 quarters.
  • Commonwealth Equity Services's Genocea Biosciences, Inc. position peaked at $56K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Commonwealth Equity Services's 13F filing for Q2 2022, filed 19 Jul 2022.